| Name | Homewood Health Campus |
|---|---|
| Location | 2494 N Lebanon St, Lebanon, Indiana |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 68 |
| Occupancy Rate | 54.56% |
| Medicare ID (CCN) | 155680 |
| Legal Business Name | Witham Memorial Hospital |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1891807566 |
| Organization Name | WITHAM MEMORIAL HOSPITAL |
| Doing Business As | HOMEWOOD HEALTH CAMPUS |
| Address | 2494 N Lebanon St, Lebanon, IN 46052 |
| Phone Number | 765-482-2076 |
News Archive
U.S. News & World Report has once again named Hospital for Special Surgery (HSS) the top hospital in the country for orthopedics in its 2011 "America's Best Hospitals" issue.
DiagnoCure, Inc., a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced that its proprietary prostate cancer biomarker PCA3 was the topic of over 13 presentations at the 2010 European Association of Urology meeting, the world largest urology event, held in Barcelona, Spain, with 14,000 registrants.
Cryo-Save today announced the European introduction of Cryo-Lip, a new product that allows the collection, processing and storage of a rich mixture of adult stem cells from liposuction aspirate (fatty tissue that is normally discarded).
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to scientific advancements in analgesia, announced that the U.S. Food and Drug Administration has accepted for review the New Drug Application for lower dose submicron indomethacin, a non-steroidal anti-inflammatory drug, for the proposed indication of treatment of mild to moderate acute pain in adults.
TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, today announced that the Company is having productive discussions with US regulators, including a very recent face-to-face meeting. The Company is actively engaged in the changing US regulatory process intended to lead to the refilling for 510(k) clearance on its new generation sterilizer.
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
U.S. News & World Report has once again named Hospital for Special Surgery (HSS) the top hospital in the country for orthopedics in its 2011 "America's Best Hospitals" issue.
DiagnoCure, Inc., a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced that its proprietary prostate cancer biomarker PCA3 was the topic of over 13 presentations at the 2010 European Association of Urology meeting, the world largest urology event, held in Barcelona, Spain, with 14,000 registrants.
Cryo-Save today announced the European introduction of Cryo-Lip, a new product that allows the collection, processing and storage of a rich mixture of adult stem cells from liposuction aspirate (fatty tissue that is normally discarded).
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to scientific advancements in analgesia, announced that the U.S. Food and Drug Administration has accepted for review the New Drug Application for lower dose submicron indomethacin, a non-steroidal anti-inflammatory drug, for the proposed indication of treatment of mild to moderate acute pain in adults.
TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, today announced that the Company is having productive discussions with US regulators, including a very recent face-to-face meeting. The Company is actively engaged in the changing US regulatory process intended to lead to the refilling for 510(k) clearance on its new generation sterilizer.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $650 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 17.59 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 13.86 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 19.35 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 5.69 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 7.08 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 5.34 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 11.9 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 98.51 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 57.36 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 12.04 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 10 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 91.98 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 65.88 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 90.06 | 82.93 |
News Archive
U.S. News & World Report has once again named Hospital for Special Surgery (HSS) the top hospital in the country for orthopedics in its 2011 "America's Best Hospitals" issue.
DiagnoCure, Inc., a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced that its proprietary prostate cancer biomarker PCA3 was the topic of over 13 presentations at the 2010 European Association of Urology meeting, the world largest urology event, held in Barcelona, Spain, with 14,000 registrants.
Cryo-Save today announced the European introduction of Cryo-Lip, a new product that allows the collection, processing and storage of a rich mixture of adult stem cells from liposuction aspirate (fatty tissue that is normally discarded).
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to scientific advancements in analgesia, announced that the U.S. Food and Drug Administration has accepted for review the New Drug Application for lower dose submicron indomethacin, a non-steroidal anti-inflammatory drug, for the proposed indication of treatment of mild to moderate acute pain in adults.
TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, today announced that the Company is having productive discussions with US regulators, including a very recent face-to-face meeting. The Company is actively engaged in the changing US regulatory process intended to lead to the refilling for 510(k) clearance on its new generation sterilizer.
› Verified 5 days ago
Signature Healthcare At Parkwood Location: 1001 N Grant St, Lebanon, Indiana 46052 Phone: (765) 482-6400 | |
Essex Nursing And Rehabilitation Center Location: 301 W Essex St, Lebanon, Indiana 46052 Phone: (765) 482-1950 | |